Get the full picture
Sign in to uncover key details.
Cofactor Genomics
Business Services · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4044 Clayton Ave, Saint Louis, Missouri,...Phone Number
(314) 531-4647Website
www.cofactorgenomics.comRevenue
$6 MillionIndustry
About Cofactor Genomics
Cofactor Genomics specializes in RNA-Seq technology, focusing on predictive diagnostics that match cancer patients to appropriate treatments. They have developed the OncoPrism assay, which accurately predicts patient responses to immunotherapy, and are currently involved in clinical trials with over 24 healthcare systems. Their innovative approach utilizes multidimensional biomarkers to enhance the understanding of tumor responses, aiming to improve precision medicine. The company targets medical oncologists, pathologists, and clinical researchers interested in immune-oncology indications.Explore more
Cofactor Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cofactor Genomics
Compare insights from companies similar to Cofactor Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cofactor Genomics Tech Stack
A closer look at the technologies used by Cofactor Genomics
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cofactor Genomics
Sign Up For FreeTo access detailed company insights
Cofactor Genomics specializes in RNA-Seq technology, focusing on predictive diagnostics that match cancer patients to appropriate treatments. They have developed the OncoPrism assay, which accurately predicts patient responses to immunotherapy, and are currently involved in clinical trials with over 24 healthcare systems. Their innovative approach... Read More
